Viking Therapeutics Statistics Share Statistics Viking Therapeutics has 112.44M
shares outstanding. The number of shares has increased by 1.37%
in one year.
Shares Outstanding 112.44M Shares Change (YoY) 1.37% Shares Change (QoQ) 0.06% Owned by Institutions (%) 67.81% Shares Floating 109.09M Failed to Deliver (FTD) Shares 35,491 FTD / Avg. Volume 0.61%
Short Selling Information The latest short interest is 27.51M, so 24.47% of the outstanding
shares have been sold short.
Short Interest 27.51M Short % of Shares Out 24.47% Short % of Float 29.36% Short Ratio (days to cover) 5.79
Valuation Ratios The PE ratio is -39.9 and the forward
PE ratio is -8.54.
Viking Therapeutics's PEG ratio is
-3.63.
PE Ratio -39.9 Forward PE -8.54 PS Ratio 0 Forward PS 448.2 PB Ratio 4.98 P/FCF Ratio -49.98 PEG Ratio -3.63
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Viking Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 33.09,
with a Debt / Equity ratio of 0.
Current Ratio 33.09 Quick Ratio 33.09 Debt / Equity 0 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.44M Employee Count 45 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -52.1% in the
last 52 weeks. The beta is 0.67, so Viking Therapeutics's
price volatility has been higher than the market average.
Beta 0.67 52-Week Price Change -52.1% 50-Day Moving Average 31.21 200-Day Moving Average 32.57 Relative Strength Index (RSI) 39.45 Average Volume (20 Days) 5,850,706
Income Statement
Revenue n/a Gross Profit n/a Operating Income -150.92M Net Income -109.96M EBITDA -109.52M EBIT -109.87M Earnings Per Share (EPS) -1.01
Full Income Statement Balance Sheet The company has 26.68M in cash and 1.12M in
debt, giving a net cash position of 25.56M.
Cash & Cash Equivalents 26.68M Total Debt 1.12M Net Cash 25.56M Retained Earnings -487.91M Total Assets 827.85M Working Capital 795.04M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -87.79M
and capital expenditures 0, giving a free cash flow of -87.79M.
Operating Cash Flow -87.79M Capital Expenditures n/a Free Cash Flow -87.79M FCF Per Share -0.81
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
